ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

UICC Merit Award Winners Announced

September 19, 1986

In Brief: Lenhard Elected President Of ACS; House Science Committee Approves CRADA Bill

November 17, 1995

Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson in U.S. News & World Report Ranking

July 15, 2014

In Brief: Karmanos Institute Names Four To Faculty; $1.5M Donated To Kaplan Cancer Center

September 11, 1998

NIH Advisors Urge Overhaul Of Peer Review System.

March 7, 2008

Tobacco Control In The States Can Reduce Use, NCPB Says.

February 18, 2000